- Atlas
- Medicine & Health
- Endocrinology And Diabetes
Endocrinology And Diabetes
Endocrinology is the branch of internal medicine that studies the glands that release hormones into the blood and the effects those hormones have on the rest of the body—growth, metabolism, reproduction, blood pressure, salt balance, and the body's response to stress.
13 frameworks, from 1500 to today · Internal Medicine · Medicine & Health
- Humoral and Glandular Anatomy Tradition 1500-1850
- Experimental Glandular Physiology 1849-1910
- Dietary and Starvation Therapy of Diabetes 1870-1922
- Hormone 1905-1960
- Insulin 1922-Present
- Steroid Hormone Biochemistry and Glucocorticoid Therapy 1930-1970
- Diabetes medication 1955-Present
- Radioimmunoassay 1959-Present
- Receptor Biology and Second-Messenger Endocrinology 1960-Present
- Molecular Genetics of Endocrine Disease 1980-Present
- Glycaemic Control and Complications Paradigm 1993-Present
- Continuous Glucose Monitoring and Automated Insulin Delivery 2005-Present
- Incretin and Organ-Protective Therapeutics 2005-Present
Overview
Endocrinology is the branch of internal medicine that studies the glands that release hormones into the blood and the effects those hormones have on the rest of the body—growth, metabolism, reproduction, blood pressure, salt balance, and the body's response to stress12. Diabetes mellitus, the condition in which blood glucose runs too high, sits at the centre of the field because it is both the most common endocrine disease and the one whose treatment has driven many of the field's technical advances. What is at stake is unusually concrete: an underactive thyroid can make a person slow, cold, and confused; an overactive adrenal gland can cause relentless high blood pressure; and poorly controlled diabetes can, over decades, blind, disable, and kill. The history of endocrinology is the history of how physicians learned that the body's organs talk to one another through chemical signals, and how they learned to measure those signals, replace them when missing, and block them when excessive.
Glands, Humours, and the First Chemical Signals
Before hormones were understood, the glands were mostly a mystery. Ancient and medieval medicine explained diseases as imbalances of four humours—blood, phlegm, yellow bile, black bile—and the glandular swellings of the neck (goitre) were attributed to "thickened" humours or to bad air and water. This humoral framework was not merely wrong; it organised observations for centuries and delayed the idea that a gland could manufacture a specific substance with a specific effect.
The first crack in the humoral picture came from anatomy. Seventeenth- and eighteenth-century anatomists dissected the thyroid, adrenals, pituitary, and gonads and described their structures, but their function remained obscure. A turning point was the recognition, during the nineteenth century, that removing a gland could produce disease. In 1849 the German physician Arnold Berthold showed that castrated roosters failed to develop normal combs and behaviour, and that transplanting testes back into the abdomen reversed the effect—an experiment implying that the testis releases a blood-borne substance. In the same period, surgeons observed that total thyroidectomy in animals and people caused weakness, swelling, and death, while the English physician Thomas Addison, in 1855, described the fatal syndrome—later Addison's disease—that follows destruction of the adrenal glands. These were not yet explanations, but they established that glands are essential organs whose removal has specific consequences.
The word "hormone," from the Greek for "to set in motion," was coined in 1905 by the physiologist Ernest Starling, who with William Bayliss had shown that the intestinal lining releases a chemical messenger, secretin, that travels in the blood to stimulate pancreatic secretion134. This was the decisive concept: a substance made in one organ, carried by blood, acting on another1. The demonstration that chemical messengers cross the body was the founding act of endocrinology as a discipline.
Diabetes Before Insulin: Diet and Starvation
Diabetes has been recognised since antiquity—the Greek physician Aretaeus described the melting away of the body into sweet urine. The sweetness was identified in the seventeenth century, and in the nineteenth the French clinician Apollinaire Bouchardat and later the German physicians established that sugar in the urine reflected a disturbance of carbohydrate metabolism, and that restricting food, especially sugar and starch, reduced it.
The first effective therapy was dietary5. Before any drug, the physicians of the late nineteenth and early twentieth centuries treated diabetes by underfeeding, and the most systematic version was the starvation therapy of Frederick Allen in the United States. Allen showed that severely restricting calories could prolong the lives of people with diabetes, but the price was chronic hunger and wasting, and children often died within a year or two. This was not a cure but a means of buying time5.
Insulin: The First Replacement Therapy
The discovery of insulin is the central turning point in the history of diabetes. In the early 1920s, at the University of Toronto, Frederick Banting and Charles Best, working under the physiologist John Macleod, prepared extracts of pancreatic tissue that lowered blood glucose in dogs167. A biochemist, James Collip, purified the extract sufficiently for use in people, and in 1922 a fourteen-year-old boy, Leonard Thompson, received it. Banting and Macleod received the Nobel Prize in 1923; Best and Collip did not, a decision long debated.
Insulin changed diabetes from a rapidly fatal disease into a chronic one. It also created a new problem: how much insulin, and when. Early insulins were short-acting extracts given several times a day, and patients and physicians learned through trial and error that the dose must be matched to food and activity. The purification and then the sequencing of insulin—its amino acid sequence was worked out in the 1950s by Frederick Sanger, and genetically engineered human insulin became available in the 1980s—made the drug safer and more predictable. Long-acting and rapid-acting analogues later allowed regimens that mimicked normal insulin secretion more closely.
Measuring Hormones: The Biochemistry of the 1930s and After
The next great advance was the ability to identify and measure hormones chemically. In the 1930s, the isolation of steroid hormones from the adrenal cortex and gonads—Edward Kendall and Philip Hench's work on cortisone, and the identification of sex steroids—showed that these hormones could be purified, dosed, and given as drugs. The synthesis of cortisone made possible the treatment of Addison's disease and, more broadly, the use of steroids as anti-inflammatory drugs, a development that reshaped many areas of medicine.
But until the 1960s, hormone measurement depended on bioassays—animal or tissue preparations that responded to a hormone and could only estimate it crudely. The revolution came with the radioimmunoassay developed by Rosalyn Yalow and Solomon Berson in the late 1950s89. The principle was elegant: a fixed amount of hormone is labelled with a radioactive isotope, and the unlabelled hormone in a patient's sample competes for binding to a specific antibody8. The more hormone in the sample, the less labelled hormone binds, and the amount can be calculated from the radioactive signal. Radioimmunoassay made it possible to measure hormones at concentrations of a billionth of a gram per millilitre, and it transformed endocrinology into a quantitative clinical science. Yalow received the Nobel Prize in 197789.
The Complications Paradigm: Diabetes Becomes a Disease of Slowly Damaging Glucose
For decades after insulin, the question was how tightly to control blood glucose. Physicians knew that high glucose over years damaged the eyes, kidneys, nerves, and blood vessels, but the evidence that tight control prevented these complications was weak. The turning point was the Diabetes Control and Complications Trial, published in 1993, which randomised people with type 1 diabetes to intensive versus conventional insulin therapy and showed that lower blood glucose substantially reduced retinopathy, nephropathy, and neuropathy. A parallel randomised trial in type 2 diabetes, the United Kingdom Prospective Diabetes Study, published in 1998, showed similar protection with intensive control.
This "glycaemic control" paradigm reshaped treatment targets, but it also revealed limits: tight control came at the cost of more serious hypoglycaemia, and in older or frail patients the benefit was less clear. The paradigm descended directly into modern practice, where glucose targets are individualised rather than universal.
Oral Drugs, Incretins, and the Biology of the Gut
Before the 1950s, type 2 diabetes had little drug therapy. The first oral agents were the sulfonylureas, introduced in the 1950s, which stimulate insulin release from the pancreas; they were later joined by metformin, a drug from the 1950s that reduces glucose production by the liver, and by other classes such as the thiazolidinediones. These drugs made type 2 diabetes manageable in primary care but were blunt tools with side effects.
A different turning point came from studying the gut. The observation that an oral glucose load triggers more insulin release than the same amount of glucose given intravenously led to the discovery of incretins—gut hormones, principally glucagon-like peptide-1 (GLP-1), that amplify insulin secretion after meals. Drugs that mimic GLP-1 or block its breakdown became available in the 2000s. Later trials showed that some of these drugs also reduce cardiovascular and kidney events, and that the sodium-glucose transporter inhibitors (SGLT2 inhibitors), a separate drug class developed earlier, protect the heart and kidney independently of glucose lowering. This "organ-protective" turn moved diabetes treatment beyond glucose numbers toward preventing the complications themselves.
Hormone Receptors and Molecular Endocrinology
The 1960s and 1970s brought the question of mechanism: how does a hormone act on a cell1? The answer came through receptor biology. In the 1960s, Earl Sutherland discovered cyclic AMP and the second-messenger principle—the idea that a hormone binding at the cell surface triggers a molecule inside the cell that carries the signal. Later work showed that steroid hormones act differently, entering the cell and binding to intracellular receptors that regulate gene expression directly3. The cloning of hormone receptors from the 1980s onward made it possible to understand diseases as receptor defects and to design drugs that block or activate specific receptors. Molecular endocrinology thus explained why a gland could be normal yet its hormone ineffective.
The other modern strand is genetics. The recognition that some endocrine diseases are inherited—including multiple endocrine neoplasia syndromes and various forms of congenital adrenal hyperplasia—led to genetic testing and counselling. More recently, the discovery of the leptin hormone in 1994 by Jeffrey Friedman and colleagues opened the biology of appetite and body-weight regulation, and human genetics has begun to identify common variants that influence diabetes risk.
Monitoring and Machines: The Present
Two technologies now define daily diabetes care. The first is continuous glucose monitoring: a small sensor worn under the skin measures glucose in the interstitial fluid every few minutes, allowing patients to see trends rather than isolated finger-stick values. The second is automated insulin delivery: a pump controlled by an algorithm that adjusts insulin based on sensor readings, sometimes called a closed-loop or "artificial pancreas."10 These systems, developed from the 2000s onward, have reduced hypoglycaemia and improved control in type 1 diabetes.
The present field is therefore a hybrid. It rests on classical glandular physiology and replacement therapy—thyroid hormone, cortisol, insulin—on the quantitative precision of radioimmunoassay and its modern analogues, on the complications paradigm of glucose control, and on a molecular pharmacology of receptors and gut hormones. Its open questions are real: how to prevent type 1 diabetes, how to reverse or prevent type 2 diabetes in the face of a global obesity epidemic, how to prevent hypoglycaemia in the most vulnerable, and how to use genetics and monitoring to individualise treatment rather than apply one target to all.
References
- Endocrinology (introduction, The endocrine system, History), Wikipedia
- Endocrine system, Wikipedia
- Nuclear receptor (History, introduction), Wikipedia
- Signal transduction (History), Wikipedia
- Diet in diabetes (History), Wikipedia
- History of diabetes, Wikipedia
- Frederick Banting, Wikipedia
- Radioimmunoassay (History, introduction), Wikipedia
- Immunoassay (History), Wikipedia
- Automated insulin delivery system, Wikipedia
The frameworks of Endocrinology And Diabetes
Each framework is a way of working the field has used: when it held, and the question it answers.
- 1500-1850
- 1849-1910
- 1870-1922
Dietary and Starvation Therapy of Diabetes
Can diet control sugar in the urine?
- 1905-1960
- 1922-Present
- 1930-1970
Steroid Hormone Biochemistry and Glucocorticoid Therapy
Can steroid hormones be purified and dosed?
- 1955-Present
- 1959-Present
- 1960-Present
Receptor Biology and Second-Messenger Endocrinology
How do hormones act on cells?
- 1980-Present
Molecular Genetics of Endocrine Disease
Which genes cause endocrine disease?
- 1993-Present
Glycaemic Control and Complications Paradigm
Does tight glucose control prevent complications?
- 2005-Present
Continuous Glucose Monitoring and Automated Insulin Delivery
Can glucose be tracked and insulin dosed automatically?
- 2005-Present
Incretin and Organ-Protective Therapeutics
Can drugs protect organs beyond lowering glucose?
How the ideas connect
Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.
Hormone grew out of Experimental Glandular Physiology
Experimental glandular physiology established that removing or transplanting glands has specific effects. Starling and Bayliss's demonstration of secretin, and Starling's 1905 coining of 'hormone', generalised this into the concept of a blood-borne chemical messenger.
Carried by Ernest Starling; William Bayliss.
Insulin grew out of Experimental Glandular Physiology
The experimental physiology of glandular extracts, including the earlier demonstration that pancreatic extracts lower glucose, was the direct basis for Banting and Best's 1921-22 isolation of insulin and its first clinical use.
Carried by Frederick Banting; Charles Best; John Macleod.
Insulin replaced Dietary and Starvation Therapy of Diabetes
Dietary restriction and Allen's starvation therapy were the only effective treatment for diabetes before 1922. Insulin replaced them as the working therapy, though diet remained an adjunct.
Carried by Frederick Allen.
Glycaemic Control and Complications Paradigm influenced by Insulin
Insulin made long survival with diabetes possible and thus made chronic complications visible. The Diabetes Control and Complications Trial (1993) tested whether intensive insulin therapy lowering glucose prevents those complications.
Carried by Diabetes Control and Complications Trial (1993).
Experimental Glandular Physiology replaced Humoral and Glandular Anatomy Tradition
The humoral and glandular anatomy tradition explained glandular disease as imbalance of humours. Berthold's 1849 testis-transplant experiment and Addison's 1855 description of adrenal destruction replaced this with the view that glands release specific blood-borne substances whose removal causes specific disease.
Carried by Arnold Berthold; Thomas Addison.
Steroid Hormone Biochemistry and Glucocorticoid Therapy grew out of Hormone
The hormone concept framed the search for specific chemical messengers. In the 1930s Kendall, Hench and others isolated and synthesised adrenal steroid hormones, turning the hormone idea into purified, dosed drugs such as cortisone.
Carried by Edward Kendall; Philip Hench.
Radioimmunoassay influenced by Hormone
The hormone concept created the need to measure trace substances in blood. Yalow and Berson's radioimmunoassay answered that need by using a specific antibody and a radioactive label to quantify hormones.
Carried by Rosalyn Yalow; Solomon Berson.
Diabetes medication influenced by Insulin
Insulin established that lowering blood glucose is the therapeutic goal in diabetes. The sulfonylureas, introduced in the 1950s, were developed as oral agents to stimulate endogenous insulin release toward that same goal.
Continuous Glucose Monitoring and Automated Insulin Delivery influenced by Insulin
Insulin therapy created the problem of matching dose to fluctuating glucose. Continuous glucose monitoring and automated insulin delivery are technical responses to that problem.
Incretin and Organ-Protective Therapeutics grew out of Diabetes medication
Oral diabetes drugs established the practice of treating type 2 diabetes with glucose-lowering agents. Incretin mimetics and SGLT2 inhibitors extended that drug-development programme with new mechanisms and organ-protective claims.
Molecular Genetics of Endocrine Disease influenced by Receptor Biology and Second-Messenger Endocrinology
Receptor biology identified hormone receptors as specific proteins. Molecular genetics then cloned the genes for these receptors and hormones, allowing endocrine disease to be traced to mutations.
Continuous Glucose Monitoring and Automated Insulin Delivery influenced by Glycaemic Control and Complications Paradigm
The glycaemic control paradigm set tight glucose targets that required frequent measurement. Continuous glucose monitoring and automated insulin delivery were developed to meet that demand.
Incretin and Organ-Protective Therapeutics influenced by Radioimmunoassay
Sensitive assays for gut hormones, descended from radioimmunoassay, allowed incretins such as GLP-1 to be measured and characterised, enabling incretin-based drugs.
Incretin and Organ-Protective Therapeutics influenced by Receptor Biology and Second-Messenger Endocrinology
Second-messenger endocrinology provided the framework for understanding how incretin receptors on pancreatic beta cells signal insulin release, which underpins incretin therapeutics.
Beyond the field
Where Endocrinology And Diabetes's ideas came from in other fields, and what they led to there: the strongest 12 of 64 links.
Experimental Glandular Physiology led to Reproductive Endocrinology in Reproductive Physiology
Reproductive endocrinology grew directly out of the experimental glandular physiology of the nineteenth century, above all Berthold's testicular transplantation experiments and later work on ovarian extracts. The organotherapy and ablation methods of that tradition became the assay and replacement techniques of the new field.
Carried by Adolf Berthold; Eugen Steinach.
Experimental Glandular Physiology influenced Endocrinology of reproduction in Theriogenology
Experimental glandular physiology, above all the demonstration that glandular extracts and transplants alter bodily function, established that the gonads and pituitary secrete substances controlling reproduction. This experimental tradition supplied the concept and methods on which reproductive endocrinology was built.
Hormone influenced by Chemical physiology and metabolism in Physiology
Chemical physiology and metabolism supplied the concept of internal secretion and the chemical methods by which the first hormones were identified and assayed.
Carried by Ernest Henry Starling.
Hormone influenced Endocrine disruptor in Environmental Toxicology
The endocrine disruptor concept rests on the classical hormone concept: the idea that trace chemical messengers act at receptors to control development and reproduction was transferred to environmental chemicals that mimic hormones.
Hormone influenced Hormonal Therapy in Medical Oncology
The isolation and chemical characterisation of steroid sex hormones in the 1920s-30s gave Huggins the agents and rationale for androgen deprivation in prostate cancer.
Carried by Charles Brenton Huggins.
Hormone influenced Plant hormone in Plant Physiology
The plant hormone concept was taken over from animal endocrinology: growth substances were sought and named as hormones after the animal hormone idea was established. Frits Went's auxin work and the earlier hormone concept in medicine supplied the model.
Carried by Frits Went; Ernest Starling.
Steroid Hormone Biochemistry and Glucocorticoid Therapy influenced by Chemical physiology and metabolism in Physiology
Chemical physiology and metabolism supplied the methods of steroid isolation, structure determination and metabolic balance study on which steroid hormone biochemistry was built.
Steroid Hormone Biochemistry and Glucocorticoid Therapy led to Topical steroid in Dermatology
Topical corticosteroids grew directly out of glucocorticoid biochemistry and systemic glucocorticoid therapy; once hydrocortisone became available, its topical application for inflammatory skin disease followed as a branch of that work.
Carried by Philip Showalter Hench.
Radioimmunoassay grew out of Quantitative Immunochemistry in Fundamental Immunology
Yalow and Berson's radioimmunoassay grew directly out of quantitative immunochemistry, using the specific binding of antibody to antigen as an analytic measuring tool. They replaced the older chemical quantitation with radioisotope-labelled antigen competition.
Carried by Rosalyn Yalow; Solomon Berson.
Receptor Biology and Second-Messenger Endocrinology influenced Insulin Resistance and Metabolic Syndrome in Metabolic Nutrition
Receptor biology and second-messenger endocrinology supplied the insulin receptor and post-receptor signalling concepts that define insulin resistance as impaired cellular response to insulin.
Incretin and Organ-Protective Therapeutics influenced by Hormonal Regulation and Homeostasis in Metabolic Nutrition
The incretin concept itself came from the hormonal regulation of homeostasis tradition: gut-derived factors stimulating insulin secretion were established by studies of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1. Incretin-based therapeutics are a direct application of that hormonal physiology.
Carried by Glucagon-like peptide-1; Glucose-dependent insulinotropic polypeptide.
Humoral and Glandular Anatomy Tradition influenced Endocrinology of reproduction in Theriogenology
The older humoral and glandular anatomy tradition, which located reproductive function in glandular organs, posed the question of what the gonads and associated glands secrete. Experimental reproductive endocrinology took up that question and answered it with the hormone concept.

Endocrinology And Diabetes is a planet in Nousfarer
Its city has a tower for each of these 13 frameworks. Land, walk in, and climb one concept at a time.
Land on Endocrinology And DiabetesRelated fields
Fields its ideas are linked to
- Metabolic Nutrition 7 links
- Cell Signaling 6 links
- Physiology 4 links
- Gastroenterology And Hepatology 4 links
- Receptor Theory And Signal Transduction 4 links
- Clinical Nutrition 4 links
- Theriogenology 3 links
- Reproductive Physiology 2 links
- Immunotherapy 2 links
- Animal Physiology 1 link
- Biochemistry 1 link
- Biology 1 link
More in Internal Medicine
- Cardiology
- Dermatology
- Gastroenterology And Hepatology
- Geriatric Medicine
- Hematology
- Infectious Diseases
- Internal Medicine
- Nephrology
- Pulmonology
- Rheumatology
See where Endocrinology And Diabetes sits on the Map of Human Knowledge